Blaine Labs Recalls Wound Care Gel Products

Potential microbial contamination prompts nationwide recall of multiple product lines

Apr. 9, 2026 at 12:50am

Got story updates? Submit your updates here. ›

An extreme close-up of the translucent X-ray image of a bandaged hand, revealing the intricate internal structures and highlighting the critical need for safe, sterile wound care products.An X-ray view exposes the internal structure of a bandaged hand, underscoring the importance of sterile, contaminant-free wound care products.Santa Fe Springs Today

Blaine Labs, Inc., a pharmaceutical company based in Santa Fe Springs, California, has issued a voluntary nationwide recall of several of its wound care gel products due to potential microbial contamination. The recall affects multiple product lots that were distributed across the United States.

Why it matters

Contaminated wound care products can pose serious health risks, including infections, if used by consumers. This recall highlights the importance of quality control and safety measures in the pharmaceutical industry to protect public health.

The details

According to the company, the recalled products were found to potentially be contaminated with microbes during the manufacturing process. The specific products affected include Blaine Labs' Hydrogel Wound Dressing, Hydrogel Wound Filler, and Hydrogel Wound Cleanser. Consumers are advised to stop using the recalled products immediately and return them to the place of purchase.

  • The recall was issued on April 8, 2026.

The players

Blaine Labs, Inc.

A pharmaceutical company based in Santa Fe Springs, California, that manufactures and distributes various wound care products.

Got photos? Submit your photos here. ›

What’s next

The U.S. Food and Drug Administration (FDA) is working with Blaine Labs to ensure the proper removal of the affected products from the market.

The takeaway

This recall underscores the critical importance of rigorous quality control and safety protocols in the pharmaceutical industry to protect consumers from potential health risks associated with contaminated medical products.